Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.20%
- Poor long term growth as Net Sales has grown by an annual rate of 2.70% and Operating profit at -240.72% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Mar 25
3
Risky -
Stock DNA
Software Products
CNY 4,558 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.02
-9.04%
5.47
Revenue and Profits:
Net Sales:
87 Million
(Quarterly Results - Sep 2025)
Net Profit:
6 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.96%
0%
-9.96%
6 Months
-2.37%
0%
-2.37%
1 Year
22.68%
0%
22.68%
2 Years
47.76%
0%
47.76%
3 Years
-11.91%
0%
-11.91%
4 Years
11.17%
0%
11.17%
5 Years
-26.62%
0%
-26.62%
Suzhou MedicalSystem Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.70%
EBIT Growth (5y)
-240.72%
EBIT to Interest (avg)
0.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.29
Tax Ratio
9.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.20%
ROE (avg)
2.28%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.75
EV to EBIT
-26.53
EV to EBITDA
-43.28
EV to Capital Employed
4.79
EV to Sales
11.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-18.07%
ROE (Latest)
-20.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
86.80
103.20
-15.89%
Operating Profit (PBDIT) excl Other Income
5.40
-49.50
110.91%
Interest
2.10
18.80
-88.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.40
-90.90
107.04%
Operating Profit Margin (Excl OI)
62.10%
-699.30%
76.14%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -15.89% vs -47.13% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is 107.04% vs -182.30% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
459.50
612.10
-24.93%
Operating Profit (PBDIT) excl Other Income
-154.30
-198.10
22.11%
Interest
72.20
48.80
47.95%
Exceptional Items
-31.30
-2.30
-1,260.87%
Consolidate Net Profit
-277.60
-265.20
-4.68%
Operating Profit Margin (Excl OI)
-547.20%
-389.00%
-15.82%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -24.93% vs 102.15% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -4.68% vs -847.04% in Dec 2023
About Suzhou MedicalSystem Technology Co., Ltd. 
Suzhou MedicalSystem Technology Co., Ltd.
Software Products
No Details Available.
Company Coordinates 
No Company Details Available






